Sheets Smith Wealth Management Exelixis, Inc. Transaction History
Sheets Smith Wealth Management
- $832 Million
- Q2 2025
A detailed history of Sheets Smith Wealth Management transactions in Exelixis, Inc. stock. As of the latest transaction made, Sheets Smith Wealth Management holds 11,778 shares of EXEL stock, worth $537,076. This represents 0.06% of its overall portfolio holdings.
Number of Shares
11,778Holding current value
$537,076% of portfolio
0.06%Shares
4 transactions
Others Institutions Holding EXEL
# of Institutions
641Shares Held
256MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.53 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.31 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$1.03 Billion4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$676 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$538 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $14.7B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...